These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7158508)

  • 21. Modulation of antitumor immunity--immunobiologic approaches.
    North RJ; Dye ES; Mills CD; Chandler JP
    Springer Semin Immunopathol; 1982; 5(2):193-220. PubMed ID: 6293113
    [No Abstract]   [Full Text] [Related]  

  • 22. Enhancement of thermal response of normal and malignant tissues by Corynebacterium parvum.
    Urano M; Yamashita T; Suit HD; Gerweck LE
    Cancer Res; 1984 Jun; 44(6):2341-7. PubMed ID: 6722772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced thermal response of a rat sarcoma by Corynebacterium parvum.
    Shah SA
    Cancer Lett; 1985 Mar; 26(2):235-40. PubMed ID: 3978610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C. parvum treatment of transplanted rat tumours of spontaneous origin.
    Willmott N; Pimm MV; Baldwin RW
    Int J Cancer; 1979 Sep; 24(3):323-8. PubMed ID: 385514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of host immunoglobulins with solid tumours in vivo.
    James K; Bessos YH; Merriman J
    Br J Cancer; 1979 Nov; 40(5):689-700. PubMed ID: 315785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of anti-thymocyte serum, anti-macrophage serum, and latex particles on the therapeutic efficacy of BCG or Corynebacterium liquefaciens (Propionibacterium acnes C7) in syngeneic mice.
    Tanaka T; Nakagawa H; Kato A; Yoshimura M; Fujita H; Kimura K
    Gan; 1977 Feb; 68(1):45-52. PubMed ID: 324858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The activation state of macrophage subpopulations from a murine fibrosarcoma.
    Moore K; McBride WH
    Int J Cancer; 1980 Nov; 26(5):609-15. PubMed ID: 6263810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of C. parvum and active specific immunotherapy on intracerebral transplants of a murine fibrosarcoma.
    Woodruff MF; Hitchcock E; Whitehead VL
    Br J Cancer; 1977 May; 35(5):687-92. PubMed ID: 861152
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficacy of Corynebacterium parvum treatment of mice with sarcoma growing in normal or irradiated tissue.
    Suit HD; Sedlacek R; Echteler S
    Cancer Res; 1977 Nov; 37(11):4233-4. PubMed ID: 908052
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunoprophylaxis and immunotherapy for a murine fibrosarcoma with C. granulosum and C. parvum.
    Milas L; Gutterman JU; Basic I; Hunter N; Mavligit GM; Hersh EM; Withers HR
    Int J Cancer; 1974 Oct; 14(4):493-503. PubMed ID: 4459276
    [No Abstract]   [Full Text] [Related]  

  • 31. In vitro antitumor effect of lymphoid cells from Corynebacterium parvum-treated mice: effect of route of C. parvum administration.
    Ghaffar A; Cullen RT
    J Natl Cancer Inst; 1977 Mar; 58(3):717-20. PubMed ID: 300113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiation response of C3H fibrosarcoma enhanced in mice stimulated by Corynebacterium parvum.
    Suit HD; Sedlacek R; Wagner M; Orsi L
    Nature; 1975 Jun; 255(5508):493-4. PubMed ID: 1138200
    [No Abstract]   [Full Text] [Related]  

  • 33. Macrophage mediated tumor cell cytotoxicity.
    Kaplan AM; Morahan PS
    Ann N Y Acad Sci; 1976; 276():134-45. PubMed ID: 1071961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Possible mechanisms in the anti-tumour activity of C. parvum.
    Cullen RT
    Dev Biol Stand; 1977 Apr 13-15; 38():265-71. PubMed ID: 305375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of C. parvum on growth and induction of intracerebral tumours in mice.
    Osborn DE; Sadler TE; Castro JE
    Br J Cancer; 1977 Apr; 35(4):420-5. PubMed ID: 857825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor growth inhibition and potentiation of immunotherapy by indomethacin in mice.
    Lynch NR; Salomon JC
    J Natl Cancer Inst; 1979 Jan; 62(1):117-21. PubMed ID: 281566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macrophage and T lymphocyte content of tumors in mice treated with Propionibacterium.
    Roszkowski K; Roszkowski W; Ko HL; Pulverer G; Jeljaszewicz J
    Oncology; 1981; 38(6):334-9. PubMed ID: 6975454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proceedings: Immunotherapy of Moloney sarcoma virus tumours in mice with Corynebacterium parvum.
    Hamilton DN; Bell PR
    Br J Surg; 1974 Apr; 61(4):321. PubMed ID: 4832648
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunospecific regression of methylcholanthrene fibrosarcoma with the use of neuraminidase.
    Simmons RL; Rios A; Lundgren G; Ray PK; McKhann CF; Haywood GR
    Surgery; 1971 Jul; 70(1):38-46. PubMed ID: 5092115
    [No Abstract]   [Full Text] [Related]  

  • 40. Macrophage heterogeneity in tumor resistance: cytostatic and cytotoxic activity of Corynebacterium parvum-activated and proteose peptone-elicited rat macrophages against Moloney sarcoma tumor cells.
    Campbell MW; Sholley MM; Miller GA
    Cell Immunol; 1980 Mar; 50(1):153-68. PubMed ID: 7397781
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.